| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
2.35 |
| Equity |
95.64 |
| Trep |
2.01 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
30.48% |
| Top 10 Holdings |
47.41% |
| Top 25 Holdings |
80.84% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
61.89 |
| Healthcare |
20.51 |
| Cash |
4.36 |
| Personal Products |
3.19 |
| Food Beverage & Tobacco |
2.17 |
| FMCG |
1.74 |
| Industrial Products |
1.67 |
| Miscellaneous |
1.54 |
| Retail |
1.31 |
| Agricultural & Farm Machinery |
0.69 |
| Technology |
0.53 |
| Chemicals |
0.4 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.74 |
| PE Ratio |
45.80 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
7.86 |
| Sun Pharmaceutical Industries Limited |
7.21 |
| Apollo Hospitals Enterprise Limited |
6.29 |
| Cipla Limited |
5.61 |
| Fortis Health Care Ltd |
3.51 |
| Biocon Limited |
3.45 |
| Emcure Pharmaceuticals Limited |
3.45 |
| Dr Reddys Laboratories Limited |
3.44 |
| Dr Lal Path Labs Ltd |
3.34 |
| Neuland Laboratories Limited |
3.25 |
| Piramal Pharma Limited |
3.02 |
| Syngene International Limited |
2.93 |
| Glenmark Pharmaceuticals Limited |
2.85 |
| Aurobindo Pharma Limited |
2.69 |
| Pfizer Limited |
2.54 |
| Net Receivables / (Payables) |
2.35 |
| IPCA Laboratories Limited |
2.11 |
| Lupin Limited |
2.08 |
| Tri Party Repo |
2.01 |
| SANOFI CONSUMER HEALTHCARE |
1.98 |
| Godrej Consumer Products Limited |
1.88 |
| VIJAYA DIAGNOSTIC CENTRE LIMITED |
1.88 |
| Hindustan Unilever Limited |
1.74 |
| Glaxosmithkline Pharma Ltd |
1.69 |
| Zydus Wellness Limited |
1.68 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
